Why the Approval of this New Alzheimer’s Drug is So Greatly Disturbing

Drugs that mess with the body’s physiology provide a false sense of control—at a grave cost. Last week, the Food and Drug Administration ignored the advice of its own expert advisory committee and approved the first new treatment for Alzheimer’s in 18 years. Called Aduhelm, it carries a substantial risk of painful brain swelling and bleeding, … Continue reading Why the Approval of this New Alzheimer’s Drug is So Greatly Disturbing